No annual revenue total was found in NUVEEN CHURCHILL DIRECT LENDING CORP.'s SEC filings.
As of Sep 30, 2026 it held $3.6 million in cash and investments and $1.0 billion in total debt.
Revenue
—
Net income (TTM)
$44.19M
-44.2% vs year-ago TTM
Operating cash flow (TTM)
$139.46M
-21.5% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$0.89
-41.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
49.39M
-5.0% vs prior year
Net cash
$-1.04B
as of Sep 30, 2026
Operating margin
—
Company profile
- Listed as
- NCDL (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- MD
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1737924
- Former names
- Nuveen Churchill BDC INC. (until Jun 2, 2020); Nuveen Churchill BDC LLC (until Dec 23, 2019)
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
|---|---|---|---|
| Net income | $65.6M | $116.3M | $75.9M |
| Diluted EPS | $1.86 | $2.26 | $2.52 |
| Operating cash flow | $194.2M | -$297.2M | -$369.5M |
| Total assets | $2.1B | $2.1B | $1.7B |
| Total liabilities | $1.2B | $1.2B | $983.0M |
| Stockholders' equity | $875.2M | $970.3M | $747.9M |
| Cash and investments | $8.6M | $2.4M | $67.4M |
| Total debt | $1.1B | $1.1B | $951.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 10, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2026 | May 21, 2026 |
All 357 Nuveen Churchill Direct Lending Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.